Linezolid and Rifampicin Combination to Combat <i>cfr</i>-Positive Multidrug-Resistant MRSA in Murine Models of Bacteremia and Skin and Skin Structure Infection.

Front Microbiol · 2019 · PMC6971047 · PMID 31993042

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Linezolid monotherapy resulted in uniform and highly significant reductions of MRSA densities in all the target tissues of mice infected with cfr -negative MRSA isolates 161400 and HYXC4.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.